Jun 8, 2024, 10:07
Ari Rosenberg: Our OPTIMA II trial is out in JAMA Oncology
Ari Rosenberg, Medical Oncologist and Assistant Professor at the University of Chicago, shared a post on X: ,
“Excited that our OPTIMA II trial is out in JAMA Oncology!
Neoadjuvant nivolumab/chemotherapy -> response-adaptive treatment for HPV+ oropharyngeal cancer.”
Proceed to the article.
Source: Ari Rosenberg/X